Literature DB >> 28529586

Immunohistochemical analysis of NANOG expression and epithelial-mesenchymal transition in pulmonary sarcomatoid carcinoma.

Takeshi Tamaki1, Toshiki Shimizu1, Maiko Niki1, Michiomi Shimizu1, Tohru Nishizawa1, Shosaku Nomura1.   

Abstract

Pulmonary sarcomatoid carcinomas (PSCs) are defined as a group of poorly differentiated non-small cell lung cancers that demonstrate sarcoma-like differentiation. The mechanism of mesenchymal differentiation in PSC is epithelial-mesenchymal transition (EMT). The expression of homeobox protein NANOG (NANOG), which regulates the pluripotency of embryonic stem cells, is associated with the EMT process. Therefore, the present study aimed to assess the expression level of NANOG and the status of the EMT process in PSC. The data of patients with PSC were retrospectively reviewed and immunohistochemical analyses were performed on patient samples to examine the expression of NANOG and EMT-associated proteins. The comparator group included randomly selected patients with matched clinicopathological characteristics who had pulmonary adenocarcinoma (PA). In the present study, 12 patients with PSC (4 females and 8 males) were enrolled; their median age was 65 years (range, 36-79 years), and the number of patients with stage IB, IIB, IIIA, IIIB and IV disease were 1, 1, 1, 1 and 8, respectively. The immunoreactive score (IRS) for E-cadherin was significantly lower in the PSC group compared with the PA group (P<0.0001), whereas the IRS for vimentin was significantly higher in the PSC group compared with the PA group (P<0.0001). However, the IRS for NANOG was significantly decreased in the PSC group compared with the PA group (P<0.0001), which suggests that NANOG does not serve an essential role in EMT in PSC. In addition, the overall survival of patients with PSC was significantly lower compared with that of patients with PA (median survival time, 7.0 vs. 35.6 months, respectively; P=0.0256). However, no significant difference was observed in the OS of patients who expressed low compared with high levels of NANOG (P=0.4416). In conclusion, it was clearly demonstrated that cytoplasmic NANOG expression was significantly lower in PSC compared with PA, and that the EMT process in PSC was accelerated, compared with that in PA.

Entities:  

Keywords:  E-cadherin; EMT; PSC; homeobox protein NANOG; p38 mitogen-activated protein kinase; vimentin; zinc finger protein SNAIL

Year:  2017        PMID: 28529586      PMCID: PMC5431690          DOI: 10.3892/ol.2017.5864

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  43 in total

1.  p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.

Authors:  V A Holst; S Finkelstein; T V Colby; J L Myers; S A Yousem
Journal:  Am J Surg Pathol       Date:  1997-07       Impact factor: 6.394

2.  Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.

Authors:  Yongmiao Pan; Jie Jiao; Caiyun Zhou; Qi Cheng; Yuting Hu; Huaizeng Chen
Journal:  Pathobiology       Date:  2011-01-24       Impact factor: 4.342

3.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

4.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

5.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

6.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.

Authors:  N A Bhowmick; M Ghiassi; A Bakin; M Aakre; C A Lundquist; M E Engel; C L Arteaga; H L Moses
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

7.  Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma.

Authors:  Yukio Nakatani; Yohei Miyagi; Tamiko Takemura; Teruaki Oka; Toyoharu Yokoi; Masayuki Takagi; Shigeo Yokoyama; Kenji Kashima; Kazuo Hara; Tetsuya Yamada; Akinori Nozawa; Yoshiaki Inayama; Kazuhiro Sakamoto; Nobuo Ogawa; Hitoshi Kitamura; Milan Resl; Sang-Ho Cho; Michael N Koss; Eugene J Mark
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

8.  Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.

Authors:  Su-Feng Chen; Yaoh-Shiang Lin; Shu-Wen Jao; Yun-Ching Chang; Chia-Lin Liu; Yu-Ju Lin; Shin Nieh
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

9.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells.

Authors:  G Greenburg; E D Hay
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

10.  Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.

Authors:  Weiren Luo; Siyi Li; Bailu Peng; Yanfen Ye; Xubin Deng; Kaitai Yao
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

View more
  2 in total

1.  Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients.

Authors:  Aleksandra Markiewicz; Anna Nagel; Jolanta Szade; Hanna Majewska; Jaroslaw Skokowski; Barbara Seroczynska; Tomasz Stokowy; Marzena Welnicka-Jaskiewicz; Anna J Zaczek
Journal:  Transl Oncol       Date:  2018-04-16       Impact factor: 4.243

2.  Fermented Ginseng Extract, BST204, Suppresses Tumorigenesis and Migration of Embryonic Carcinoma through Inhibition of Cancer Stem Cell Properties.

Authors:  Jong Woo Park; Jee Hun Park; Jeung-Whan Han
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.